Cover Image

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

Soon Jun Hong,1,* Ki-Chul Sung,2,* Sang-Wook Lim,3 Seok-Yeon Kim,4 Weon Kim,5 Jinho Shin,6 Sungha Park,7 Hae-Young Kim,8 Moo-Yong Rhee9,10 On behalf of MH_APOLLO to read: HM_APOLLO1Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hong SJ (Author), Sung KC (Author), Lim SW (Author), Kim SY (Author), Kim W (Author), Shin J (Author), Park S (Author), Kim HY (Author), Rhee MY (Author)
Format:	Book
Published:	Dove Medical Press, 2020-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study [Corrigendum]
by: Hong SJ, et al.
Published: (2021)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020)

A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
by: Eun-Seok Jeon, et al.
Published: (2022)

TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS
by: O. D. Ostroumova, et al.
Published: (2018)

Adherence to triple‐component antihypertensive regimens is higher with single‐pill than equivalent two‐pill regimens: A randomized controlled trial
by: Jidong Sung, et al.
Published: (2021)

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
by: Rhee MY, et al.
Published: (2015)

USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES
by: V. R. Abdrakhmanov, et al.
Published: (2015)

USE OF URAPIDIL - ANTIHYPERTENSIVE DRUG WITH DOUBLE ACTION - NEW DIRECTION IN TREATMENT OF HYPERTENSIVE CRISES
by: V. R. Abdrakhmanov, et al.
Published: (2015)

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
by: Kim S, et al.
Published: (2014)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
by: Ihm SH, et al.
Published: (2016)

Evaluation of antihypertensive therapy in diabetic hypertensive patients: impact of ischemic heart disease
by: Shraim NY, et al.
Published: (2009)

A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Rising‐Dose Study of the BTK Inhibitor TAK‐020 in Healthy Subjects
by: Ehsanollah Esfandiari, et al.
Published: (2021)

Randomized, double‐blind, phase 1a single‐ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers
by: William K. Schmidt, et al.
Published: (2024)

A Double‐Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects
by: Azra Hussaini, et al.
Published: (2020)

Randomized, double-blind, placebo-controlled phase I dose escalation study of Dan Qi Tong Mai tablet in healthy volunteers
by: Zhong-ping Gou, et al.
Published: (2019)

Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
by: Su Won Lee, et al.
Published: (2022)

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
by: Lee J, et al.
Published: (2017)

Choice Between Free Combination of Antihypertensive Agents and Fixed Dosed Combinations in the Treatment of Arterial Hypertension
by: O. S. Levchenkova, et al.
Published: (2024)

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension
by: Shin MS, et al.
Published: (2016)

Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial
by: Thomas Lung, PhD, et al.
Published: (2019)

Effects of Interval Training Under Hypoxia on the Autonomic Nervous System and Arterial and Hemorheological Function in Healthy Women
by: Park HY, et al.
Published: (2022)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
by: Park JS, et al.
Published: (2016)

Hypertension and Headache: the Effect of Antihypertensive Drugs
by: V. A. Parfenov, et al.
Published: (2019)

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects
by: Liu C, et al.
Published: (2019)

A phase I randomized, double‐blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects
by: Kenan Gu, et al.
Published: (2022)

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
by: Ravi Shankar P. Singh, et al.
Published: (2021)

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects
by: Won Suk Choi, et al.
Published: (2017)

Anti-Wrinkle Efficacy of Edible Bird's Nest Extract: A Randomized, Double-Blind, Placebo-Controlled, Comparative Study
by: Hyung Mook Kim, et al.
Published: (2022)

Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
by: Chao AC, et al.
Published: (2024)

Effect of herbal preparation HemoHIM on fatigue level and exercise performance: A randomized, placebo-controlled, double-blind, and parallel clinical trial
by: Ji-won Seo, et al.
Published: (2022)

Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
by: Gyu Chul Oh, et al.
Published: (2017)

Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
by: Anthony Rodgers, et al.
Published: (2024)

A Randomized Double-blind Comparative Study of the Efficacy of Eradication Therapy and Motilitone for Functional Dyspepsia
by: Jae Yong Park, et al.
Published: (2019)

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
by: A. David Burden, et al.
Published: (2023)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
by: Xue Zhao, et al.
Published: (2023)

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease
by: Gi-Ae Kim, et al.
Published: (2023)

Dose proportionality and pharmacokinetics of carvedilol sustained-release formulation: a single dose-ascending 10-sequence incomplete block study
by: Kim YH, et al.
Published: (2015)

Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole
by: Jean-Marc Bohbot, et al.
Published: (2010)

Combined antihypertensive effect of unripe Rubus coreanus Miq. and Dendropanax morbiferus H. Lév. Extracts in 1 kidney-1 clip hypertensive rats and spontaneously hypertensive rats
by: Soyi Park, et al.
Published: (2021)

Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study)
by: Jung-Yeon Choi, et al.
Published: (2020)